In these uncertain times, Narcotica aims to not only give our listeners vital public health information, but also offer a sense of reassurance and community. If you’re following the social distancing guidelines, or working from home, life may feel a little extra lonely right now, and we aim to provide interviews and conversations to keep you company.
On Tuesday March 17, co-hosts Troy Farah and Zachary Siegel interviewed Daniel Raymond, policy director at the Harm Reduction Coalition. Drawing from the wisdom and of the harm reduction community, Raymond wrote a beautiful post, “Harm Reduction in the Time of Coronavirus.” This episode covers how harm reduction is an asset during a pandemic, as well as how naloxone and syringe distribution programs are operating, methadone and buprenorphine policies and regulations, and much more.
“As we confront COVID-19/SARS-CoV-2, let us remember the gifts of harm reduction.” – Daniel Raymond, Harm Reduction Coalition. @DanielBRaymond
Follow Narcotica on Facebook, Twitter and support us on Patreon. Your support is appreciated! We’re on Spotify, iTunes, YouTube, Stitcher and more. Tell your friends about us!
Note: This episode has been slightly updated to have better mixed audio and credits.
COVID-19 (Coronavirus): How to keep drug use safe during the pandemic https://psychosafety.cf/article/1
Medium Post: https://medium.com/@danielraymond/harm-reduction-in-the-time-of-coronavirus-553e16c76623
Harm Reduction Coalition: Virtual office hours
Covid-19: Guidance for people who use drugs and harm reduction programs
NIDA: Potential implications for individuals with substance use disorders
SAMHSA: Guidance for Opioid Treatment Programs
DEA: Diversion Control Division, Telemedicine, Medications
Producers: Christopher Moraff, Troy Farah, Zachary Siegel
Co-producer: Garrett Farah
Music: Glass Boy / Pictures of the Floating World
Podcast: Play in new window | Download